Compile Data Set for Download or QSAR
Report error Found 816 of affinity data for UniProtKB/TrEMBL: Q14289
TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM286349(US9518060, Example K7 | US11220518, Ex. No. K7 | U...)
Affinity DataKi:  0.165nMpH: 7.4Assay Description:Protein Kinase C beta 2 (PKCβII) catalyzes the production of ADP from ATP that accompanies the phosphoryl transfer to the PKC Pseudosubstrate pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM286350(US9518060, Example K8 | US11220518, Ex. No. K8 | U...)
Affinity DataKi:  0.181nMpH: 7.4Assay Description:Protein Kinase C beta 2 (PKCβII) catalyzes the production of ADP from ATP that accompanies the phosphoryl transfer to the PKC Pseudosubstrate pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM286348(US9518060, Example K6 | US11220518, Ex. No. K6 | U...)
Affinity DataKi:  0.376nMpH: 7.4Assay Description:Protein Kinase C beta 2 (PKCβII) catalyzes the production of ADP from ATP that accompanies the phosphoryl transfer to the PKC Pseudosubstrate pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM418609(N-methyl-4-({4-[({2- [methyl(methylsulfonyl)amino]...)
Affinity DataIC50: 0.600nMAssay Description:Inhibition of human pyk2More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2022
Entry Details Article
PubMed
TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM50207353(CHEMBL3949755)
Affinity DataIC50: 0.670nMAssay Description:Inhibition of full length recombinant human N-terminal His6-tagged PYK2 expressed in baculovirus infected sf21 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/28/2018
Entry Details Article
PubMed
TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM286347(US9518060, Example K5 | US11220518, Ex. No. K5 | U...)
Affinity DataKi:  0.683nMpH: 7.4Assay Description:Protein Kinase C beta 2 (PKCβII) catalyzes the production of ADP from ATP that accompanies the phosphoryl transfer to the PKC Pseudosubstrate pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM50207349(CHEMBL3958414)
Affinity DataIC50: 0.840nMAssay Description:Inhibition of full length recombinant human N-terminal His6-tagged PYK2 expressed in baculovirus infected sf21 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/28/2018
Entry Details Article
PubMed
TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM50207350(CHEMBL3956954)
Affinity DataIC50: 0.900nMAssay Description:Inhibition of full length recombinant human N-terminal His6-tagged PYK2 expressed in baculovirus infected sf21 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/28/2018
Entry Details Article
PubMed
TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM286345(US9518060, Example K3 | US11220518, Ex. No. K3 | U...)
Affinity DataKi:  0.912nMpH: 7.4Assay Description:Protein Kinase C beta 2 (PKCβII) catalyzes the production of ADP from ATP that accompanies the phosphoryl transfer to the PKC Pseudosubstrate pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM286246(5-{[(8S)-6,8-dimethyl-6,9-diazaspiro[4.5]dec-9-yl]...)
Affinity DataKi:  1.01nMpH: 7.4Assay Description:Protein Kinase C beta 2 (PKCβII) catalyzes the production of ADP from ATP that accompanies the phosphoryl transfer to the PKC Pseudosubstrate pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM482158(TAE684 | BDBM50242742)
Affinity DataKd:  1.10nMAssay Description:Binding constant for PYK2 kinase domainMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/19/2012
Entry Details Article
PubMed
TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM286343(N-(2-ethoxy-5-fluoropyrimidin-4-yl)-6,6-dimethyl-5...)
Affinity DataKi:  1.12nMpH: 7.4Assay Description:Protein Kinase C beta 2 (PKCβII) catalyzes the production of ADP from ATP that accompanies the phosphoryl transfer to the PKC Pseudosubstrate pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM286320(US9518060, Example J6)
Affinity DataKi:  1.17nMpH: 7.4Assay Description:Protein Kinase C beta 2 (PKCβII) catalyzes the production of ADP from ATP that accompanies the phosphoryl transfer to the PKC Pseudosubstrate pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM418606(N-[3-({[2-anilino-5- (trifluoromethyl)pyrimidin-4-...)
Affinity DataKi:  1.20nMAssay Description:Inhibition of full-length PYK2 (unknown origin) with C-terminal NanoLuc-fusion expressed in HEK293T cells by NanoBRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
PubMed
TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM50207355(CHEMBL3987106)
Affinity DataIC50: 1.30nMAssay Description:Inhibition of full length recombinant human N-terminal His6-tagged PYK2 expressed in baculovirus infected sf21 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/28/2018
Entry Details Article
PubMed
TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM50318884(CHEMBL1084546 | CHEMBL2430359 | N-methyl-N-(3-((2-...)
Affinity DataIC50: 1.40nMAssay Description:Inhibition of pyk2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2022
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM50207365(CHEMBL3899046)
Affinity DataIC50: 1.5nMAssay Description:Inhibition of full length recombinant human N-terminal His6-tagged PYK2 expressed in baculovirus infected sf21 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/28/2018
Entry Details Article
PubMed
TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM50318884(CHEMBL1084546 | CHEMBL2430359 | N-methyl-N-(3-((2-...)
Affinity DataKi:  1.5nMAssay Description:Inhibition of full-length PYK2 (unknown origin) with C-terminal NanoLuc-fusion expressed in HEK293T cells by NanoBRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
PubMedPDB3D3D Structure (crystal)
TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM50207356(CHEMBL3969464)
Affinity DataIC50: 1.60nMAssay Description:Inhibition of full length recombinant human N-terminal His6-tagged PYK2 expressed in baculovirus infected sf21 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/28/2018
Entry Details Article
PubMed
TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM286270(US9518060, Example E2 | US11220518, Ex. No. E2 | U...)
Affinity DataKi:  1.64nMpH: 7.4Assay Description:Protein Kinase C beta 2 (PKCβII) catalyzes the production of ADP from ATP that accompanies the phosphoryl transfer to the PKC Pseudosubstrate pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM286377(US9518060, Example L4 | US11220518, Ex. No. L4 | U...)
Affinity DataKi:  1.71nMpH: 7.4Assay Description:Protein Kinase C beta 2 (PKCβII) catalyzes the production of ADP from ATP that accompanies the phosphoryl transfer to the PKC Pseudosubstrate pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM286310(N-(5-fluoro-2-propylpyrimidin-4-yl)-6,6-dimethyl-5...)
Affinity DataKi:  1.73nMpH: 7.4Assay Description:Protein Kinase C beta 2 (PKCβII) catalyzes the production of ADP from ATP that accompanies the phosphoryl transfer to the PKC Pseudosubstrate pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM50207352(CHEMBL3908093)
Affinity DataIC50: 1.90nMAssay Description:Inhibition of full length recombinant human N-terminal His6-tagged PYK2 expressed in baculovirus infected sf21 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/28/2018
Entry Details Article
PubMed
TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM50246378(N-(2-{[2-(2,2-Dioxo-2,3-dihydro-1H-2lambda6-benzo[...)
Affinity DataIC50: 2nMAssay Description:Inhibition of GST-tagged pyk2 assessed as inhibition of poly-Glu-Tyr phosphorylationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM286260(US9518060, Example B3 | US11220518, Ex. No. B3 | U...)
Affinity DataKi:  2.03nMpH: 7.4Assay Description:Protein Kinase C beta 2 (PKCβII) catalyzes the production of ADP from ATP that accompanies the phosphoryl transfer to the PKC Pseudosubstrate pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM286327(N-[5-fluoro-2-(methoxymethyl)pyrimidin-4-yl]-6,6-d...)
Affinity DataKi:  2.10nMpH: 7.4Assay Description:Protein Kinase C beta 2 (PKCβII) catalyzes the production of ADP from ATP that accompanies the phosphoryl transfer to the PKC Pseudosubstrate pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM286344(US9518060, Example K2 | US11220518, Ex. No. K2 | U...)
Affinity DataKi:  2.11nMpH: 7.4Assay Description:Protein Kinase C beta 2 (PKCβII) catalyzes the production of ADP from ATP that accompanies the phosphoryl transfer to the PKC Pseudosubstrate pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM50653104(CHEMBL5722987)
Affinity DataKi:  2.30nMAssay Description:Inhibition of full-length PYK2 (unknown origin) with C-terminal NanoLuc-fusion expressed in HEK293T cells by NanoBRET assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sidPDB
In Depth
Date in BDB:
TBA
Entry Details
PubMed
TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM286264(US9518060, Example B6 | US11220518, Ex. No. B6 | U...)
Affinity DataKi:  2.43nMpH: 7.4Assay Description:Protein Kinase C beta 2 (PKCβII) catalyzes the production of ADP from ATP that accompanies the phosphoryl transfer to the PKC Pseudosubstrate pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM50653106(CHEMBL5722946)
Affinity DataKi:  2.60nMAssay Description:Inhibition of full-length PYK2 (unknown origin) with C-terminal NanoLuc-fusion expressed in HEK293T cells by NanoBRET assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sidPDB
In Depth
Date in BDB:
TBA
Entry Details
PubMed
TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM50207354(CHEMBL3961368)
Affinity DataIC50: 2.60nMAssay Description:Inhibition of full length recombinant human N-terminal His6-tagged PYK2 expressed in baculovirus infected sf21 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/28/2018
Entry Details Article
PubMed
TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM286316(US9518060, Example J3)
Affinity DataKi:  2.63nMpH: 7.4Assay Description:Protein Kinase C beta 2 (PKCβII) catalyzes the production of ADP from ATP that accompanies the phosphoryl transfer to the PKC Pseudosubstrate pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM286227(N4-(6,6-dimethyl-5-{[(2S)-2,4,5,5-tetramethylpiper...)
Affinity DataKi:  2.69nMpH: 7.4Assay Description:Protein Kinase C beta 2 (PKCβII) catalyzes the production of ADP from ATP that accompanies the phosphoryl transfer to the PKC Pseudosubstrate pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM50207362(CHEMBL3977870)
Affinity DataIC50: 2.70nMAssay Description:Inhibition of full length recombinant human N-terminal His6-tagged PYK2 expressed in baculovirus infected sf21 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/28/2018
Entry Details Article
PubMed
TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM50207361(CHEMBL3889951)
Affinity DataIC50: 3.10nMAssay Description:Inhibition of full length recombinant human N-terminal His6-tagged PYK2 expressed in baculovirus infected sf21 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/28/2018
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM286346(US9518060, Example K4 | US11220518, Ex. No. K4 | U...)
Affinity DataKi:  3.33nMpH: 7.4Assay Description:Protein Kinase C beta 2 (PKCβII) catalyzes the production of ADP from ATP that accompanies the phosphoryl transfer to the PKC Pseudosubstrate pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM286244(US9518060, Example A8 | US11220518, Ex. No. A8 | U...)
Affinity DataKi:  3.39nMpH: 7.4Assay Description:Protein Kinase C beta 2 (PKCβII) catalyzes the production of ADP from ATP that accompanies the phosphoryl transfer to the PKC Pseudosubstrate pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM2579(CHEMBL388978 | Staurosporine, 8 | Staurosporin, 4 ...)
Affinity DataKd:  3.5nMAssay Description:Binding constant for full-length PTK2BMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/25/2012
Entry Details Article
PubMed
TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM2579(CHEMBL388978 | Staurosporine, 8 | Staurosporin, 4 ...)
Affinity DataKd:  3.5nMAssay Description:Binding constant for PYK2 kinase domainMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/19/2012
Entry Details Article
PubMed
TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM31096(CHEMBL290084 | Staurosporine | cid_451705 | US2024...)
Affinity DataKd:  3.5nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2011
Entry Details
PCBioAssay
TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM50207348(CHEMBL3912281)
Affinity DataIC50: 3.5nMAssay Description:Inhibition of full length recombinant human N-terminal His6-tagged PYK2 expressed in baculovirus infected sf21 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/28/2018
Entry Details Article
PubMed
TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM50269948(PF-228 | 6-(4-(3-(methylsulfonyl)benzylamino)-5-(t...)
Affinity DataKi:  3.60nMAssay Description:Inhibition of full-length PYK2 (unknown origin) with C-terminal NanoLuc-fusion expressed in HEK293T cells by NanoBRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
PubMed
TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM286311(US9518060, Example I2 | US11220518, Ex. No. I2 | U...)
Affinity DataKi:  3.67nMpH: 7.4Assay Description:Protein Kinase C beta 2 (PKCβII) catalyzes the production of ADP from ATP that accompanies the phosphoryl transfer to the PKC Pseudosubstrate pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM286242(US9518060, Example A7 | US11220518, Ex. No. A7 | U...)
Affinity DataKi:  3.81nMpH: 7.4Assay Description:Protein Kinase C beta 2 (PKCβII) catalyzes the production of ADP from ATP that accompanies the phosphoryl transfer to the PKC Pseudosubstrate pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM286239(US9518060, Example A5 | US11220518, Ex. No. A5 | U...)
Affinity DataKi:  3.95nMpH: 7.4Assay Description:Protein Kinase C beta 2 (PKCβII) catalyzes the production of ADP from ATP that accompanies the phosphoryl transfer to the PKC Pseudosubstrate pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM286380(N-(4-ethoxypyrimidin-2-yl)-6,6-dimethyl-5-{[(2S,5R...)
Affinity DataKi:  4.24nMpH: 7.4Assay Description:Protein Kinase C beta 2 (PKCβII) catalyzes the production of ADP from ATP that accompanies the phosphoryl transfer to the PKC Pseudosubstrate pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM50246239(N-methyl-N-(2-((2-(1-oxoisoindolin-5-ylamino)-5-(t...)
Affinity DataIC50: 5nMAssay Description:Inhibition of GST-tagged pyk2 assessed as inhibition of poly-Glu-Tyr phosphorylationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM286257(N2-ethyl-5-fluoro-N4-(5-{[(2S,5R)-4-(3-methoxyprop...)
Affinity DataKi:  5.09nMpH: 7.4Assay Description:Protein Kinase C beta 2 (PKCβII) catalyzes the production of ADP from ATP that accompanies the phosphoryl transfer to the PKC Pseudosubstrate pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM286267(N-(2-ethyl-5-fluoropyrimidin-4-yl)-6,6-dimethyl-5-...)
Affinity DataKi:  5.43nMpH: 7.4Assay Description:Protein Kinase C beta 2 (PKCβII) catalyzes the production of ADP from ATP that accompanies the phosphoryl transfer to the PKC Pseudosubstrate pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM50318884(CHEMBL1084546 | CHEMBL2430359 | N-methyl-N-(3-((2-...)
Affinity DataKd:  5.70nMAssay Description:Binding affinity to human recombinant PYK2 (amino acids 420-691) expressed in Escherichia coli, BL21 (DE3) assessed as equilibrium dissociation const...More data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
PubMedPDB3D3D Structure (crystal)
Displayed 1 to 50 (of 816 total ) | Next | Last >>
Jump to: